Qualcomm's claim alleges that Arm is in violation of the licensing agreement between both companies by misrepresenting the relationship between the two corporations to Qualcomm's customers ...

The legal battle centered on Qualcomm's use of the Oryon CPU cores in the Snapdragon X-series chips that power Copilot+ AI PCs. The cores were based on licensed Arm technology that was developed ...

SAN FRANCISCO (MarketWatch) -- Qualcomm Inc. shares lost ground Tuesday, retreating as investors reacted to the company suffering a pair of setbacks in its long-running legal battle with rival ...

Qualcomm laid out its global beef in its Delaware countersuit, saying that following Arm’s acquisition by Japan’s SoftBank Group Corp. and the failure of an attempted sale to Nvidia Corp ...

Alphawave shareholders have the option of receiving $2.48 per share in cash, a nearly 96% premium to the price on March 31, which was immediately before Qualcomm disclosed its interest in the company.

Qualcomm is poised to report a year-over-year revenue slump and lower earnings. Investors will look for updates on the chip maker’s Federal Trade Commission case, China trade and 5G phones.

Concerns over hold-up problems with RAND licensing have raised questions about its use in the IP policies of standards-setting organizations. George W Jordan III offers guidance on avoiding RAND ...

Qualcomm has launched a global antitrust campaign against Arm as the two longtime business partners jockey for advantage in the computing semiconductor market. The article requires paid subscription.